A nurse is caring for a client who is recovering from an amputation of her right arm below the elbow. Which of the following information should the nurse report to the occupational therapist?

Choice A reason: Aspirin is contraindicated in peptic ulcer disease due to its antiplatelet and gastric irritant effects, risking bleeding or ulcer exacerbation. Acetaminophen is safer. Administering aspirin risks gastrointestinal hemorrhage, critical to avoid in ensuring safe pain management for clients with a history of peptic ulcers.

Choice B reason: Ibuprofen, an NSAID, irritates the gastric mucosa, worsening peptic ulcers and increasing bleeding risk, making it unsuitable. Acetaminophen is preferred. Administering ibuprofen risks ulcer perforation or bleeding, critical to prevent in ensuring safe headache relief for clients with a peptic ulcer history.

Choice C reason: Ketorolac, an NSAID, is contraindicated in peptic ulcer disease due to its potent gastric irritant effects, risking ulcer aggravation or bleeding. Acetaminophen is safe. Administering ketorolac risks severe gastrointestinal complications, critical to avoid in providing safe pain management for clients with peptic ulcer history.

Choice D reason: Acetaminophen is safe for headache relief in peptic ulcer clients, lacking gastric irritant effects, avoiding risks of bleeding or ulcer worsening. Administering it ensures effective pain management, critical for client comfort, preventing gastrointestinal complications, and supporting safe care in clients with a history of peptic ulcers.

Choice A reason: Increased blood pressure is not an effect of furosemide, which reduces fluid volume, lowering pressure. Weight loss indicates efficacy. Assuming increased pressure is correct risks misinterpreting diuresis, potentially delaying further fluid management, critical to avoid in treating fluid volume excess effectively.

Choice B reason: Decreased pain is unrelated to furosemide’s diuretic action, which targets fluid reduction, evidenced by weight loss. Assuming pain reduction is an indicator risks missing fluid status changes, critical to prevent in ensuring accurate assessment of furosemide’s effectiveness in fluid volume excess treatment.

Choice C reason: Decreased inflammation is not a furosemide effect; it promotes diuresis, reducing fluid, shown by weight loss. Assuming inflammation reduction is relevant risks misjudging medication efficacy, potentially overlooking fluid overload signs, critical to avoid in managing fluid volume excess with diuretic therapy.

Choice D reason: Weight loss indicates furosemide’s effectiveness, as it reduces fluid volume excess through diuresis, decreasing edema and body weight. This is critical for assessing therapeutic response, ensuring fluid balance, preventing complications like heart failure, and guiding further treatment in clients with fluid overload.